CA-63-LW25_0.01uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.01uM, 4-(3-Fluoro-4-methoxyphenyl)-5,16-diazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(10),2,4,6,8,11(15)-hexaen-12-one, TNF-alpha Release Inhibitors;MAPKAP-K2 (MK2) Inhibitors targeting MAPKAPK2 (Novartis, 25066619)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/25066619
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
4 genes differentially expressed following the CA-63-LW25_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
ELOB
|
elongin B
|
0.324756
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
C1ORF56
|
chromosome 1 open reading frame 56
|
-0.324756
|
|
ZFYVE27
|
zinc finger, FYVE domain containing 27
|
-0.248977
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
-0.248977
|